The microtubule-associated protein, tau, is the principal component of paired helical filaments (PHFs) in Alzheimer's disease. PHF-tau is highly phosphorylated and a total of 25 sites of phosphorylation have so far been identified. Many of these sites are serine or threonine residues that are immediately followed in the sequence by proline residues, and hence are candidate phosphorylation sites for proline-directed kinases. In vitro, glycogen synthase kinase-3 (GSK-3), extracellular signal-related kinase-1 and -2, and mitogen-activated protein kinases, p38 kinase and c-jun N-terminal kinase, all phosphorylate many of these sites, although with different efficiencies for particular sites. Phosphorylation studies in transfected cells and neurons show that GSK-3 phosphorylates tau more extensively than do these other proline-directed kinases. Mutations in tau have been shown to affect in vitro phosphorylation of tau by GSK-3. The Arg406-->Trp (R406W) tau mutation also affects tau phosphorylation in cells.
Sites of phosphorylation in tau and factors affecting their regulation
- Views Icon Views
- Share Icon Share
Cora O'Neill, Brian Anderton, Brian H. Anderton, Joanna Betts, Walter P. Blackstock, Jean-Pierre Brion, Sara Chapman, James Connell, Rejith Dayanandan, Jean-Marc Gallo, Graham Gibb, Diane P. Hanger, Mike Hutton, Efterpi Kardalinou, Karell Leroy, Simon Lovestone, Till Mack, C.Hugh Reynolds, M. Van Slegtenhorst; Sites of phosphorylation in tau and factors affecting their regulation. Biochem Soc Symp 1 February 2001; 67 73–80. doi: https://doi.org/10.1042/bss0670073
Download citation file: